What you need to know
As public interest grows in the potential for psychedelic substances to treat mental illness and addictions, it is becoming more important for service providers to become educated about how to support clients interested in psychedelic use. In this peer-reviewed article, the researchers highlight the promise of harm reduction and integration therapy (HRIT) and discuss legal and ethical considerations, along with ways to lessen risks to both clients and clinicians engaging with the topic of psychedelics.
----------------------------------------------
EENet's Research Viewpoints provide opinions from experts in the field of mental health and addictions and are based on commentary or editorials published in peer-reviewed journals.
This latest Research Viewpoint is based on the article “Ethical and legal issues in psychedelic harm reduction and integration therapy” published in Harm Reduction Journal in 2021. DOI: 10.1186/s12954-021-00489-1
Read the full Research Viewpoint in English here or in French here.
For other EENet content related to this subject matter, check out our webinar series on psychedelic-assisted therapies and medicine.